Publications by authors named "Shaochen Zheng"
Background: Previous studies have confirmed the safety and feasibility of half-dose ticagrelor in Chinese patients with acute coronary syndrome, but currently there is no plan for the use of ticagrelor for Chinese ST-segment elevation myocardial infarction (STEMI) patients.
Hypothesis: It is safe and feasible of low-dose ticagrelor in patients with STEMI.
Methods: The STEMI patients who were undergoing emergency intervention and taking ticagrelor were enrolled.